Skip to main content

Table 3 Changes in risperidone doses

From: Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia

Group

Baseline

4 weeks

12 weeks

20 weeks

26 weeks

34 weeks

52 weeks

(mg/d)

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

4-week dose

4.4

0.8

4.2

0.8

2.2a

0.4

2.2

0.5

2.1

0.4

2.1

0.4

2.1

0.4

26-week dose

4.2

0.5

4.2

0.6

4.2

0.5

4.2

0.5

3.8

0.9

2.1b

0.3

2.0

0.3

Therapeutic dose

4.3

0.6

4.3

0.6

4.2

0.7

4.3

0.6

4.2

0.6

4.3

0.6

4.2

0.6

  1. aMean doses when the dose reduction was completed in the 4-week group
  2. bMean doses when the dose reduction was completed in the 26-week group
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us